An Investigational Drug Study in Obese (Considerably Overweight) Patients (0364-006)(COMPLETED)
This study has been completed.
Information provided by:
First received: April 22, 2005
Last updated: August 29, 2013
Last verified: August 2013
The purpose of this study is to determine the safety and effectiveness of an investigational drug in patients with obesity (considerably overweight).
|Study Design:||Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Investigator)
Primary Purpose: Treatment
|Official Title:||A Study to Assess the Safety and Efficacy of MK0364 in Obese Patients|
Resource links provided by NLM:
Further study details as provided by Merck:
Contacts and Locations